A relevant percentage of @entity1 with @entity5 are not candidates for surgery when the diagnosis is made. Endoscopically placed biliary stents have shown their efficacy in the palliative management of these @entity1 although they do not seem to increase their survival. We report on a retrospective analysis of 37 @entity1 with @entity5 treated with endoscopic biliary stents. The distal third (62%) of the main life duct was the most frequent common location for the obstruction, and @entity788 was the most frequent cause of obstruction (64%). Twenty three plastic (13-7F and 10-10F) and 14 metallic stents were placed initially. Forty four percent of the plastic stents (all of them 7F, none 10F) were removed after 39 days against 30% of the metallic stents after a mean period of 60 days. Global survival was 153 days (110 in the plastic stents' group versus 195 in the metallic one, p: NS). We could only make a complete follow up in 52% of the @entity1 . CONCLUSIONS: endoprotheses are a good palliative treatment for @entity5 . When plastic stents are used they should have a wide calibre (10F or greater). Metallic stents result in an increase of survival time without statistical significance.

Endoscopic stenting in the management of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatic cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignant biliary obstruction']
@entity5 :: (MESH:D009369,Disease) :: ['malignant biliary obstruction']
